Literature DB >> 15841185

Bcl-2-related protein A1 is an endogenous and cytokine-stimulated mediator of cytoprotection in hyperoxic acute lung injury.

Chuan Hua He1, Aaron B Waxman, Chun Geun Lee, Holger Link, Morgan E Rabach, Bing Ma, Qingsheng Chen, Zhou Zhu, Mei Zhong, Keiko Nakayama, Keiichi I Nakayama, Robert Homer, Jack A Elias.   

Abstract

Hyperoxic acute lung injury (HALI) is characterized by a cell death response with features of apoptosis and necrosis that is inhibited by IL-11 and other interventions. We hypothesized that Bfl-1/A1, an antiapoptotic Bcl-2 protein, is a critical regulator of HALI and a mediator of IL-11-induced cytoprotection. To test this, we characterized the expression of A1 and the oxygen susceptibility of WT and IL-11 Tg(+) mice with normal and null A1 loci. In WT mice, 100% O(2) caused TUNEL(+) cell death, induction and activation of intrinsic and mitochondrial-death pathways, and alveolar protein leak. Bcl-2 and Bcl-xl were also induced as an apparent protective response. A1 was induced in hyperoxia, and in A1-null mice, the toxic effects of hyperoxia were exaggerated, Bcl-2 and Bcl-xl were not induced, and premature death was seen. In contrast, IL-11 stimulated A1, diminished the toxic effects of hyperoxia, stimulated Bcl-2 and Bcl-xl, and enhanced murine survival in 100% O(2). In A1-null mice, IL-11-induced protection, survival advantage, and Bcl-2 and Bcl-xl induction were significantly decreased. VEGF also conferred protection via an A1-dependent mechanism. In vitro hyperoxia also stimulated A1, and A1 overexpression inhibited oxidant-induced epithelial cell apoptosis and necrosis. A1 is an important regulator of oxidant-induced lung injury, apoptosis, necrosis, and Bcl-2 and Bcl-xl gene expression and a critical mediator of IL-11- and VEGF-induced cytoprotection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15841185      PMCID: PMC1070412          DOI: 10.1172/JCI23004

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  55 in total

Review 1.  Morphologic changes in pulmonary oxygen toxicity.

Authors:  J D Crapo
Journal:  Annu Rev Physiol       Date:  1986       Impact factor: 19.318

Review 2.  Biology of disease: free radicals and tissue injury.

Authors:  B A Freeman; J D Crapo
Journal:  Lab Invest       Date:  1982-11       Impact factor: 5.662

3.  Evaluation of survival data and two new rank order statistics arising in its consideration.

Authors:  N Mantel
Journal:  Cancer Chemother Rep       Date:  1966-03

4.  Bcl-2 family gene expression during severe hyperoxia induced lung injury.

Authors:  M A O'Reilly; R J Staversky; H L Huyck; R H Watkins; M B LoMonaco; C T D'Angio; R B Baggs; W M Maniscalco; G S Pryhuber
Journal:  Lab Invest       Date:  2000-12       Impact factor: 5.662

5.  The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-kappaB that blocks TNFalpha-induced apoptosis.

Authors:  W X Zong; L C Edelstein; C Chen; J Bash; C Gélinas
Journal:  Genes Dev       Date:  1999-02-15       Impact factor: 11.361

6.  Tracheal insufflation of tumor necrosis factor protects rats against oxygen toxicity.

Authors:  M F Tsan; J E White; T A Santana; C Y Lee
Journal:  J Appl Physiol (1985)       Date:  1990-03

7.  Transgenic overexpression of granulocyte macrophage-colony stimulating factor in the lung prevents hyperoxic lung injury.

Authors:  Robert Paine; Steven E Wilcoxen; Susan B Morris; Claudio Sartori; Carlos E O Baleeiro; Michael A Matthay; Paul J Christensen
Journal:  Am J Pathol       Date:  2003-12       Impact factor: 4.307

8.  Vascular endothelial growth factor (VEGF) induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung.

Authors:  Chun Geun Lee; Holger Link; Peter Baluk; Robert J Homer; Svetlana Chapoval; Vineet Bhandari; Min Jong Kang; Lauren Cohn; Yoon Keun Kim; Donald M McDonald; Jack A Elias
Journal:  Nat Med       Date:  2004-09-19       Impact factor: 53.440

9.  Necrotic cell death in response to oxidant stress involves the activation of the apoptogenic caspase-8/bid pathway.

Authors:  Xue Wang; Stefan W Ryter; Chunsun Dai; Zi-Lue Tang; Simon C Watkins; Xiao-Ming Yin; Ruiping Song; Augustine M K Choi
Journal:  J Biol Chem       Date:  2003-05-15       Impact factor: 5.157

10.  Recombinant tumor necrosis factor/cachectin and interleukin 1 pretreatment decreases lung oxidized glutathione accumulation, lung injury, and mortality in rats exposed to hyperoxia.

Authors:  C W White; P Ghezzi; C A Dinarello; S A Caldwell; I F McMurtry; J E Repine
Journal:  J Clin Invest       Date:  1987-06       Impact factor: 14.808

View more
  43 in total

1.  NALP-3 inflammasome silencing attenuates ceramide-induced transepithelial permeability.

Authors:  Narasaiah Kolliputi; Lakshmi Galam; Prasanna Tamarapu Parthasarathy; Srinivas M Tipparaju; Richard F Lockey
Journal:  J Cell Physiol       Date:  2012-09       Impact factor: 6.384

Review 2.  BCL2A1: the underdog in the BCL2 family.

Authors:  M Vogler
Journal:  Cell Death Differ       Date:  2011-11-11       Impact factor: 15.828

Review 3.  Role of hyperoxic treatment in cancer.

Authors:  Sei W Kim; In K Kim; Sang H Lee
Journal:  Exp Biol Med (Maywood)       Date:  2020-04-23

4.  To live or die: a critical decision for the lung.

Authors:  G R Scott Budinger; Jacob I Sznajder
Journal:  J Clin Invest       Date:  2005-04       Impact factor: 14.808

Review 5.  Acute lung injury and the acute respiratory distress syndrome: four decades of inquiry into pathogenesis and rational management.

Authors:  Michael A Matthay; Guy A Zimmerman
Journal:  Am J Respir Cell Mol Biol       Date:  2005-10       Impact factor: 6.914

6.  p21Cip1 protection against hyperoxia requires Bcl-XL and is uncoupled from its ability to suppress growth.

Authors:  Peter F Vitiello; Rhonda J Staversky; Sean C Gehen; Carl J Johnston; Jacob N Finkelstein; Terry W Wright; Michael A O'Reilly
Journal:  Am J Pathol       Date:  2006-06       Impact factor: 4.307

7.  Regulation of Bcl-xL expression in lung vascular smooth muscle.

Authors:  Yuichiro J Suzuki; Hiroko Nagase; Chi Ming Wong; Shilpashree Vinod Kumar; Vivek Jain; Ah-Mee Park; Regina M Day
Journal:  Am J Respir Cell Mol Biol       Date:  2007-02-01       Impact factor: 6.914

8.  Effects of age on the synergistic interactions between lipopolysaccharide and mechanical ventilation in mice.

Authors:  Lincoln S Smith; Sina A Gharib; Charles W Frevert; Thomas R Martin
Journal:  Am J Respir Cell Mol Biol       Date:  2009-11-09       Impact factor: 6.914

9.  Anti-apoptotic proteins BCL-2, MCL-1 and A1 summate collectively to maintain survival of immune cell populations both in vitro and in vivo.

Authors:  Emma M Carrington; Yifan Zhan; Jamie L Brady; Jian-Guo Zhang; Robyn M Sutherland; Natasha S Anstee; Robyn L Schenk; Ingela B Vikstrom; Rebecca B Delconte; David Segal; Nicholas D Huntington; Philippe Bouillet; David M Tarlinton; David Cs Huang; Andreas Strasser; Suzanne Cory; Marco J Herold; Andrew M Lew
Journal:  Cell Death Differ       Date:  2017-03-31       Impact factor: 15.828

10.  Epithelial ablation of Bcl-XL increases sensitivity to oxygen without disrupting lung development.

Authors:  Rhonda J Staversky; Peter F Vitiello; Min Yee; Linda M Callahan; David A Dean; Michael A O'Reilly
Journal:  Am J Respir Cell Mol Biol       Date:  2009-10-30       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.